Drug-coated Coronary Artery Stent (Novolimus) - Vietnam Registration 2403500ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug-coated Coronary Artery Stent (Novolimus) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại D medical device is registered under number 2403500ĐKLH/BYT-HTTB and manufactured by Elixir Medical Corporation. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN ĐẦU TƯ PHÁT TRIỂN TMT VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403500ĐKLH/BYT-HTTB
000.00.04.G18-231229-0011
Theo theo phụ lục
Theo phụ lục
Technical Details
The drug-eluting coronary stent with Novolimus is a permanently implanted device that combines the drug, Novolimus, and aims to improve the coronary artery diameter in patients with symptomatic coronary artery disease.
Dates and Status
Nov 14, 2024

